カテゴリー： Market Monitor Global, 世界, 医療/バイオ

後天性血友病A治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Acquired hemophilia A Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5622）◆商品コード：MMG23JU5622
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：78
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Acquired hemophilia A Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの後天性血友病A治療薬市場規模と予測を収録しています。・世界の後天性血友病A治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の後天性血友病A治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の後天性血友病A治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「200IU」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

後天性血友病A治療薬のグローバル主要企業は、Sanofiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、後天性血友病A治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の後天性血友病A治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の後天性血友病A治療薬市場：タイプ別市場シェア、2022年
・200IU、250IU

世界の後天性血友病A治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の後天性血友病A治療薬市場：用途別市場シェア、2022年
・病院、薬局

世界の後天性血友病A治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の後天性血友病A治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における後天性血友病A治療薬のグローバル売上、2018年-2023年
・主要企業における後天性血友病A治療薬のグローバル売上シェア、2022年
・主要企業における後天性血友病A治療薬のグローバル販売量、2018年-2023年
・主要企業における後天性血友病A治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi

*************************************************************

・調査・分析レポートの概要
後天性血友病A治療薬市場の定義
市場セグメント
世界の後天性血友病A治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の後天性血友病A治療薬市場規模
世界の後天性血友病A治療薬市場規模：2022年 VS 2029年
世界の後天性血友病A治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの後天性血友病A治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の後天性血友病A治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：200IU、250IU
後天性血友病A治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
後天性血友病A治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別後天性血友病A治療薬市場規模 2022年と2029年
地域別後天性血友病A治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi
...

ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer.
This report aims to provide a comprehensive presentation of the global market for Acquired hemophilia A Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acquired hemophilia A Drugs. This report contains market size and forecasts of Acquired hemophilia A Drugs in global, including the following market information:
Global Acquired hemophilia A Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Acquired hemophilia A Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Acquired hemophilia A Drugs companies in 2022 (%)
The global Acquired hemophilia A Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
200IU Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acquired hemophilia A Drugs include Sanofi. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acquired hemophilia A Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acquired hemophilia A Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acquired hemophilia A Drugs Market Segment Percentages, by Type, 2022 (%)
200IU
250IU
Global Acquired hemophilia A Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acquired hemophilia A Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Acquired hemophilia A Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acquired hemophilia A Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acquired hemophilia A Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Acquired hemophilia A Drugs revenues share in global market, 2022 (%)
Key companies Acquired hemophilia A Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Acquired hemophilia A Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acquired hemophilia A Drugs, market overview.
Chapter 2: Global Acquired hemophilia A Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Acquired hemophilia A Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acquired hemophilia A Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Acquired hemophilia A Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Acquired hemophilia A Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acquired hemophilia A Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acquired hemophilia A Drugs Overall Market Size
2.1 Global Acquired hemophilia A Drugs Market Size: 2022 VS 2029
2.2 Global Acquired hemophilia A Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Acquired hemophilia A Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Acquired hemophilia A Drugs Players in Global Market
3.2 Top Global Acquired hemophilia A Drugs Companies Ranked by Revenue
3.3 Global Acquired hemophilia A Drugs Revenue by Companies
3.4 Global Acquired hemophilia A Drugs Sales by Companies
3.5 Global Acquired hemophilia A Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Acquired hemophilia A Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Acquired hemophilia A Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Acquired hemophilia A Drugs Players in Global Market
3.8.1 List of Global Tier 1 Acquired hemophilia A Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Acquired hemophilia A Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Acquired hemophilia A Drugs Market Size Markets, 2022 & 2029
4.1.2 200IU
4.1.3 250IU
4.2 By Type – Global Acquired hemophilia A Drugs Revenue & Forecasts
4.2.1 By Type – Global Acquired hemophilia A Drugs Revenue, 2018-2023
4.2.2 By Type – Global Acquired hemophilia A Drugs Revenue, 2024-2029
4.2.3 By Type – Global Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Acquired hemophilia A Drugs Sales & Forecasts
4.3.1 By Type – Global Acquired hemophilia A Drugs Sales, 2018-2023
4.3.2 By Type – Global Acquired hemophilia A Drugs Sales, 2024-2029
4.3.3 By Type – Global Acquired hemophilia A Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Acquired hemophilia A Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Acquired hemophilia A Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Acquired hemophilia A Drugs Revenue & Forecasts
5.2.1 By Application – Global Acquired hemophilia A Drugs Revenue, 2018-2023
5.2.2 By Application – Global Acquired hemophilia A Drugs Revenue, 2024-2029
5.2.3 By Application – Global Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Acquired hemophilia A Drugs Sales & Forecasts
5.3.1 By Application – Global Acquired hemophilia A Drugs Sales, 2018-2023
5.3.2 By Application – Global Acquired hemophilia A Drugs Sales, 2024-2029
5.3.3 By Application – Global Acquired hemophilia A Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Acquired hemophilia A Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Acquired hemophilia A Drugs Market Size, 2022 & 2029
6.2 By Region – Global Acquired hemophilia A Drugs Revenue & Forecasts
6.2.1 By Region – Global Acquired hemophilia A Drugs Revenue, 2018-2023
6.2.2 By Region – Global Acquired hemophilia A Drugs Revenue, 2024-2029
6.2.3 By Region – Global Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Acquired hemophilia A Drugs Sales & Forecasts
6.3.1 By Region – Global Acquired hemophilia A Drugs Sales, 2018-2023
6.3.2 By Region – Global Acquired hemophilia A Drugs Sales, 2024-2029
6.3.3 By Region – Global Acquired hemophilia A Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Acquired hemophilia A Drugs Revenue, 2018-2029
6.4.2 By Country – North America Acquired hemophilia A Drugs Sales, 2018-2029
6.4.3 US Acquired hemophilia A Drugs Market Size, 2018-2029
6.4.4 Canada Acquired hemophilia A Drugs Market Size, 2018-2029
6.4.5 Mexico Acquired hemophilia A Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Acquired hemophilia A Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Acquired hemophilia A Drugs Sales, 2018-2029
6.5.3 Germany Acquired hemophilia A Drugs Market Size, 2018-2029
6.5.4 France Acquired hemophilia A Drugs Market Size, 2018-2029
6.5.5 U.K. Acquired hemophilia A Drugs Market Size, 2018-2029
6.5.6 Italy Acquired hemophilia A Drugs Market Size, 2018-2029
6.5.7 Russia Acquired hemophilia A Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Acquired hemophilia A Drugs Market Size, 2018-2029
6.5.9 Benelux Acquired hemophilia A Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Acquired hemophilia A Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Acquired hemophilia A Drugs Sales, 2018-2029
6.6.3 China Acquired hemophilia A Drugs Market Size, 2018-2029
6.6.4 Japan Acquired hemophilia A Drugs Market Size, 2018-2029
6.6.5 South Korea Acquired hemophilia A Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Acquired hemophilia A Drugs Market Size, 2018-2029
6.6.7 India Acquired hemophilia A Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Acquired hemophilia A Drugs Revenue, 2018-2029
6.7.2 By Country – South America Acquired hemophilia A Drugs Sales, 2018-2029
6.7.3 Brazil Acquired hemophilia A Drugs Market Size, 2018-2029
6.7.4 Argentina Acquired hemophilia A Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Acquired hemophilia A Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Acquired hemophilia A Drugs Sales, 2018-2029
6.8.3 Turkey Acquired hemophilia A Drugs Market Size, 2018-2029
6.8.4 Israel Acquired hemophilia A Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Acquired hemophilia A Drugs Market Size, 2018-2029
6.8.6 UAE Acquired hemophilia A Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Acquired hemophilia A Drugs Major Product Offerings
7.1.4 Sanofi Acquired hemophilia A Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
8 Global Acquired hemophilia A Drugs Production Capacity, Analysis
8.1 Global Acquired hemophilia A Drugs Production Capacity, 2018-2029
8.2 Acquired hemophilia A Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Acquired hemophilia A Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Acquired hemophilia A Drugs Supply Chain Analysis
10.1 Acquired hemophilia A Drugs Industry Value Chain
10.2 Acquired hemophilia A Drugs Upstream Market
10.3 Acquired hemophilia A Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Acquired hemophilia A Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Acquired hemophilia A Drugs in Global Market
Table 2. Top Acquired hemophilia A Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Acquired hemophilia A Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Acquired hemophilia A Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Acquired hemophilia A Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Acquired hemophilia A Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Acquired hemophilia A Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Acquired hemophilia A Drugs Product Type
Table 9. List of Global Tier 1 Acquired hemophilia A Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acquired hemophilia A Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Acquired hemophilia A Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Acquired hemophilia A Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Acquired hemophilia A Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Acquired hemophilia A Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Acquired hemophilia A Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Acquired hemophilia A Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Acquired hemophilia A Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Acquired hemophilia A Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Acquired hemophilia A Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Acquired hemophilia A Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Acquired hemophilia A Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Acquired hemophilia A Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Acquired hemophilia A Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Acquired hemophilia A Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Acquired hemophilia A Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Acquired hemophilia A Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Acquired hemophilia A Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Acquired hemophilia A Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Acquired hemophilia A Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Acquired hemophilia A Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Acquired hemophilia A Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Acquired hemophilia A Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Acquired hemophilia A Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Acquired hemophilia A Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Acquired hemophilia A Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Acquired hemophilia A Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Acquired hemophilia A Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Acquired hemophilia A Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Acquired hemophilia A Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Acquired hemophilia A Drugs Sales, (K Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Acquired hemophilia A Drugs Product Offerings
Table 48. Sanofi Acquired hemophilia A Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Acquired hemophilia A Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Acquired hemophilia A Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Acquired hemophilia A Drugs Production by Region, 2018-2023 (K Units)
Table 53. Global Acquired hemophilia A Drugs Production by Region, 2024-2029 (K Units)
Table 54. Acquired hemophilia A Drugs Market Opportunities & Trends in Global Market
Table 55. Acquired hemophilia A Drugs Market Drivers in Global Market
Table 56. Acquired hemophilia A Drugs Market Restraints in Global Market
Table 57. Acquired hemophilia A Drugs Raw Materials
Table 58. Acquired hemophilia A Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Acquired hemophilia A Drugs Downstream
Table 60. Acquired hemophilia A Drugs Downstream Clients in Global Market
Table 61. Acquired hemophilia A Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Acquired hemophilia A Drugs Segment by Type in 2022
Figure 2. Acquired hemophilia A Drugs Segment by Application in 2022
Figure 3. Global Acquired hemophilia A Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acquired hemophilia A Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Acquired hemophilia A Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Acquired hemophilia A Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Acquired hemophilia A Drugs Revenue in 2022
Figure 9. By Type - Global Acquired hemophilia A Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Acquired hemophilia A Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Acquired hemophilia A Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Acquired hemophilia A Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Acquired hemophilia A Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Acquired hemophilia A Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Acquired hemophilia A Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Acquired hemophilia A Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Acquired hemophilia A Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Acquired hemophilia A Drugs Sales Market Share, 2018-2029
Figure 23. US Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Acquired hemophilia A Drugs Sales Market Share, 2018-2029
Figure 28. Germany Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Acquired hemophilia A Drugs Sales Market Share, 2018-2029
Figure 37. China Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Acquired hemophilia A Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Acquired hemophilia A Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Acquired hemophilia A Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Acquired hemophilia A Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Acquired hemophilia A Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Acquired hemophilia A Drugs by Region, 2022 VS 2029
Figure 54. Acquired hemophilia A Drugs Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 後天性血友病A治療薬の世界市場見通し2023年-2029年(Acquired hemophilia A Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 後天性血友病A治療薬の世界市場2022：200IU、250IU
  • 血友病治療の世界市場見通し2023年-2029年
  • 血友病治療薬のグローバル市場展望 2023年-2029年：血液製品、遺伝子組み換え製品
  • シニフォルドラッグの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆